Visualize bacteria (≥ 10⁴ CFU/g) in wounds at point-of-care
MolecuLight i:X – Real-time visualization of Bacteria in wounds
What if you could SEE clinically significant ( ≥ 10⁴ CFU/g) bacteria in wounds at the point-of-care?
Introducing the MolecuLight i:X®, a revolutionary point-of-care imaging device to detect and visualize moderate-to-heavy loads (≥ 10⁴ CFU/g) of bacteria in wounds. The device is portable, has diagnostic accuracy & also performs digital wound area measurement.
Why visualizing bacteria in wounds is essential to wound care?
Visualizing clinically-significant bacteria in real-time with the MolecuLight i:X can allow for the following:
- Early detection of bacteria & immediate triaging of wound care resources
- More accurate sampling data
- Improved wound bed preparation and debridement
- Evidence-based treatment selection
- Monitoring of treatment effectiveness & improved outcomes
How can visualizing bacteria in wounds improve patient outcomes?
Clinical studies have shown that using the i:X along with the Standard of Care has been shown to put non-healing wounds on a healing trajectory while decreasing the cost of healing wounds.
The MolecuLight i:X is approved in Canada and is FDA approved
Brands: MolecuLight i:X